Antibody modeling: Implications for engineering and design

被引:86
作者
Morea, V
Lesk, AM
Tramontano, A
机构
[1] IRBM P Angeletti, I-00040 Rome, Italy
[2] Univ G DAnnunzio, Ist Chim Farm, Chieti, Italy
[3] Univ Cambridge, Sch Clin, Wellcome Trust Ctr Study Mol Mechanisms Dis, Cambridge Inst Med Res, Cambridge CB2 2XY, England
基金
英国惠康基金;
关键词
antibody modeling; canonical structures; CDRs; loop grafting; protein engineering;
D O I
10.1006/meth.1999.0921
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Our understanding of the rules relating sequence to structure in antibodies has led to the development of accurate knowledge-based procedures for antibody modeling. Information gained from the analysis of antibody structures has been successfully exploited to engineer antibody-like molecules endowed with prescribed properties, such as increased stability or different specificity, many of which have a broad spectrum of applications both in therapy and in research. Here we describe a knowledge-based procedure for the prediction of the antibody-variable domains, based on the canonical structures method for the antigen-binding site, and discuss its expected accuracy and limitations. The rational design of antibody-based molecules is illustrated using as an example one of the most widely employed modifications of antibody structures: the humanization of animal-derived antibodies to reduce their immunogenicity for serotherapy in humans. (C) 2000 Academic Press.
引用
收藏
页码:267 / 279
页数:13
相关论文
共 102 条
[91]   CATALYTIC ANTIBODIES [J].
TRAMONTANO, A ;
JANDA, KD ;
LERNER, RA .
SCIENCE, 1986, 234 (4783) :1566-1570
[92]   FRAMEWORK RESIDUE-71 IS A MAJOR DETERMINANT OF THE POSITION AND CONFORMATION OF THE 2ND HYPERVARIABLE REGION IN THE VH DOMAINS OF IMMUNOGLOBULINS [J].
TRAMONTANO, A ;
CHOTHIA, C ;
LESK, AM .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (01) :175-182
[93]  
van Gunsteren W F, 1987, J Comput Aided Mol Des, V1, P171
[94]   Modeling side-chain conformation [J].
Vasquez, M .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1996, 6 (02) :217-221
[95]   RESHAPING HUMAN-ANTIBODIES - GRAFTING AN ANTILYSOZYME ACTIVITY [J].
VERHOEYEN, M ;
MILSTEIN, C ;
WINTER, G .
SCIENCE, 1988, 239 (4847) :1534-1536
[96]  
VITETTA ES, 1985, ANNU REV IMMUNOL, V3, P197
[97]   WHAT IF - A MOLECULAR MODELING AND DRUG DESIGN PROGRAM [J].
VRIEND, G .
JOURNAL OF MOLECULAR GRAPHICS, 1990, 8 (01) :52-&
[98]  
WEBSTER DM, 1988, INT J CANCER, P13
[99]   ANALYSIS AND PREDICTION OF THE DIFFERENT TYPES OF BETA-TURN IN PROTEINS [J].
WILMOT, CM ;
THORNTON, JM .
JOURNAL OF MOLECULAR BIOLOGY, 1988, 203 (01) :221-232
[100]   MAN-MADE ANTIBODIES [J].
WINTER, G ;
MILSTEIN, C .
NATURE, 1991, 349 (6307) :293-299